.

Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
UBS
Fuji
US Department of Justice
Chinese Patent Office
Fish and Richardson
Moodys
QuintilesIMS
McKesson
Argus Health

Generated: September 26, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 064118

« Back to Dashboard
NDA 064118 describes NYSTOP, which is a drug marketed by Paddock Llc and is included in one NDA. It is available from two suppliers. Additional details are available on the NYSTOP profile page.

The generic ingredient in NYSTOP is nystatin. There are eight drug master file entries for this compound. Fifty suppliers are listed for this compound. Additional details are available on the nystatin profile page.

Summary for NDA: 064118

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antifungals
Formulation / Manufacturing:see details

Pharmacology for NDA: 064118

Ingredient-typePolyenes

Suppliers and Packaging for NDA: 064118

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NYSTOP
nystatin
POWDER;TOPICAL 064118 ANDA Paddock Laboratories, LLC 0574-2008 0574-2008-02 60 g in 1 BOTTLE, PLASTIC (0574-2008-02)
NYSTOP
nystatin
POWDER;TOPICAL 064118 ANDA Paddock Laboratories, LLC 0574-2008 0574-2008-15 15 g in 1 BOTTLE, PLASTIC (0574-2008-15)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:POWDER;TOPICALStrength100,000 UNITS/GM
Approval Date:Aug 16, 1996TE:ATRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Merck
McKesson
Farmers Insurance
US Army
Mallinckrodt
Citi
US Department of Justice
Julphar
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot